Page 3 - Taiwanese (TAIEX) Growth Healthcare Stocks

UPDATED Nov 23, 2024

Discover Taiwanese Healthcare Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

85 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1788

Hi-Clearance
NT$138.500.4%2.6%NT$6.2bn/aPE16.7xn/a5.1%

7575

Amed
NT$44.204.9%-29.1%NT$1.3bn/an/an/a5.7%

4173

Arich Enterprise
NT$20.650.2%-5.3%NT$1.5bn/aPE19.2xn/a4.5%

6527

Crystalvue Medical
NT$89.800.7%2.9%NT$2.3bn/aPE19.7xn/a2.3%

6744

Feng Chi Biotech
NT$20.152.8%-14.8%NT$310.3mn/aPE16.1xn/a5.2%

4161

Bioptik Technology Incorporation
NT$32.70-0.9%9.0%NT$1.7bn/aPE17.4xn/a2.1%

4138

Dynamic Medical Technologies
NT$93.30-2.4%1.6%NT$3.4bn/aPE17.2xn/a6.6%

1781

Health & Life
NT$18.4511.5%31.8%NT$874.7mn/aPS1.3xn/a0%

6569

Onyx Healthcare
NT$150.001.4%-12.0%NT$5.8bn/aPE31.7xn/a2.9%

4139

Ma Kuang Healthcare Holding
NT$29.95-3.1%-19.1%NT$1.3bn/aPS1.1xn/a0%

7555

MEM Dental Technology
NT$54.00-4.8%9.1%NT$1.3bn/an/an/a0.9%

4183

EPS Bio Technology
NT$22.75-5.4%-18.8%NT$541.5mn/aPE17.9xn/a3.5%

6931

Qing Song HealthLtd
NT$100.500%71.1%NT$6.0bn/aPE123.2xn/a0.08%

1786

SciVision Biotech
NT$93.400.2%18.2%NT$6.6bNT$153.00PE30.4xS41.4%2.7%

6879

TCI GENE
NT$51.004.9%-38.7%NT$1.3bn/aPE49.3xn/a2.0%

4736

TaiDoc Technology
NT$148.500.3%-3.9%NT$14.2bn/aPE15.9xn/a6.7%

4106

Wellell
NT$24.600.8%-14.1%NT$2.5bn/aPE25.9xn/a3.3%

6649

Taiwan Biomaterial
NT$35.201.3%9.5%NT$1.5bn/aPS17.7xn/a0.6%

6797

Taiwan Advanced Nanotech
NT$21.20-0.9%-42.2%NT$651.5mn/aPS3.3xn/a0%

1733

Apex Biotechnology
NT$28.502.2%-0.2%NT$2.8bNT$36.00PE27.2xn/a3.9%

4188

AmCad BioMed
NT$20.90-1.9%-30.0%NT$1.3bn/aPS22.7xn/an/a

4115

Sunder Biomedical Tech
NT$10.20-1.0%-30.1%NT$612.0mn/an/an/an/a

6572

PlexBio
NT$12.404.2%-9.8%NT$1.3bn/aPS12.4xn/an/a

4198

S&S Healthcare Holding
NT$32.15-3.2%32.9%NT$775.1mn/aPE7.3xn/an/a
Page 3 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.